BIT
ELDN icon

BlackRock Institutional Trust’s Eledon Pharmaceuticals ELDN Stock Holding History

BlackRock Institutional Trust’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$132K Hold
834
– – ﹤0.01% 3625
2016
Q3 		$207K Buy
834
+69
+9% +$25.2K ﹤0.01% 3606
2016
Q2 		$682K Sell
765
-46
-6% -$50.7K ﹤0.01% 3428
2016
Q1 		$737K Sell
811
-16
-2% -$15.7K ﹤0.01% 3369
2015
Q4 		$1.17M Buy
827
+64
+8% +$112K ﹤0.01% 3288
2015
Q3 		$1.28M Buy
763
+380
+99% +$783K ﹤0.01% 3260
2015
Q2 		$825K Buy
383
+93
+32% +$180K ﹤0.01% 3407
2015
Q1 		$532K Buy
290
+23
+9% +$50.7K ﹤0.01% 3490
2014
Q4 		$637K Buy
+267
New +$634K ﹤0.01% 3455

Other funds holding ELDN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return